hero-icon

Blog

Interpreting the Guideline for Good Clinical Practice

Posted by: DaVita Clinical Research

The Guideline for Good Clinical Practice (GCP) is a set of guidelines written by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH).  These guidelines… Read more

DCR BioReG Update

Posted by: DaVita Clinical Research

  The DaVita Clinical Research (DCR) Biorepository Grant Program (BioReG) was formed support precision-based medicine innovation in nephrology. To see an update of the BioReG Gran Program, please click the… Read more

Nephrology Research: How Will We Find a Cure?

Posted by: DaVita Clinical Research

Chances are that you or someone you know has faced a cancer diagnosis.  It’s also likely that after a diagnosis, the possibility of participating in clinical trials was highlighted. For… Read more

Enrolling Dialysis Patients for Clinical Trials

Posted by: DaVita Clinical Research

Patient enrollment for clinical trials can be a challenging task especially if the patients are dealing with a chronic illness. Dialysis patients in particular are a population that need a… Read more

How Biosimilars Could Impact Clinical Trials

Posted by: DaVita Clinical Research

Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical products which… Read more

Kidney & Renal Failure Research

Posted by: DaVita Clinical Research

Getting people with Chronic Kidney Disease (CKD) in on the ground floor. At DaVita Clinical Research, our specialty is performing research in people with chronic kidney disease (CKD). From the… Read more